Private equity firm Bain Capital will acquire Vitabiotics, UK’s leading nutraceutical company, bolstering its presence in the expanding global market for nutrition, vitamins, minerals, and wellness supplements...
Healthcare
Tempus to buy cancer test maker Personalis for $1.5 billion
Tempus AI said on Monday it would buy Personalis in a deal valued at about $1.5 billion, adding a cancer test to the AI-enabled precision medicine firm’s oncology portfolio. Personalis shares fell 12% in morning...
Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million
Cardinal Health said on Monday it has agreed to buy AdaptHealth’s diabetes health business and medical supply provider Strive Medical in separate deals for about $360 million in total, expanding its home care...
Warburg acquires Integrace Health from Temasek and True North, hires new CEO
Global private equity firm Warburg Pincus has acquired Integrace Private Ltd, a domestic pharmaceuticals company focused on orthopedics and gynecology, and has hired Rehan Khan, a former managing director of MSD and...
Warburg, Bain, CVC among PE firms in talks to buy into Agappe Diagnostics
Warburg Pincus, TA Associates, Bain Capital, and CVC Capital are among global private equity firms in early-stage discussions to buy about 25% stake in Agappe Diagnostics, said people familiar with the matter. The...
Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows
Mylan Inc, part of a global healthcare company Viatris, plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Indian rupees ($363 million), according to a term sheet seen by...
GA-Renova & CCA in race to buy American oncology: Siemens Healthineers looking to exit non-core business for Rs 1,500 crore
A consortium of General Atlantic and Renova Hospitals, and Indian-American entrepreneur Raj Mantena’s Cancer Centers of America (CCA) are the top two contenders to buy American Oncology Institute (AOI) from...
Jagsonpal Pharma soars after inking pact to acquire majority stake in Aequitas
Jagsonpal Pharmaceuticals surged 9.79% to Rs 253.90 after the company entered into a definitive Agreement to acquire an 85% equity stake in Aequitas Healthcare (Aequitas), marking its entry into the hospital segment...
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth parent Honasa Consumer is acquiring a majority stake in Mumbai-based nutraceuticals brand Fluence Pharma at an enterprise value of ₹135 crore, according to a stock exchange filing. This marks the Gurugram...
Manipal Hospitals is said to plan $1 billion IPO in July
Manipal Health Enterprises Pvt., which runs the Manipal Hospitals chain, is likely to launch its initial public offering as early as next month, according to people familiar with the matter. The Temasek Holdings Pte...
Cloudnine’s 25% stake sale attracts top global PE firms
Global private equity firms TPG Capital, Advent International, CVC Capital Partners and Permira have been shortlisted for the next round of discussions to acquire a significant minority stake in Cloudnine, India’s...
CCI clears TVS Group’s acquisition of PGIM India AMC, Temasek-Romsons deal
Fair trade regulator CCI on Tuesday approved Chennai-based TVS Group entities’ proposal to acquire PGIM’s India asset management business and also cleared Temasek’s investment in medical devices maker...
